As of Feb 24
| +0.15 / +3.90%|
The 3 analysts offering 12-month price forecasts for Sangamo Therapeutics Inc have a median target of 5.00, with a high estimate of 13.00 and a low estimate of 4.00. The median estimate represents a +25.00% increase from the last price of 4.00.
The current consensus among 4 polled investment analysts is to Buy stock in Sangamo Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.